Montag A & Associates Inc Novartis Ag Transaction History

Montag A & Associates Inc

  • $2.09 Billion
  • Q3 2024

A detailed history of Montag A & Associates Inc transactions in Novartis Ag stock. As of the latest transaction made, Montag A & Associates Inc holds 7,575 shares of NVS stock, worth $789,921. This represents 0.04% of its overall portfolio holdings.

Number of Shares
7,575
Previous 7,575 -0.0%
Holding current value
$789,921
Previous $806,000 8.06%
% of portfolio
0.04%
Previous 0.04%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
SELL
$95.27 - $108.47 $37,917 - $43,171
-398 Reduced 4.99%
7,575 $732,000
Q4 2023

Feb 07, 2024
SELL
$92.27 - $101.54 $9,503 - $10,458
-103 Reduced 1.28%
7,973 $805,000
Q3 2023

Nov 09, 2023
SELL
$94.73 - $105.13 $18,093 - $20,079
-191 Reduced 2.31%
8,076 $822,000
Q2 2023

Aug 09, 2023
BUY
$92.52 - $104.91 $9,159 - $10,386
99 Added 1.21%
8,267 $834,000
Q1 2023

May 11, 2023
SELL
$80.03 - $92.81 $720 - $835
-9 Reduced 0.11%
8,168 $751,000
Q4 2022

Feb 02, 2023
SELL
$75.55 - $92.52 $29,011 - $35,527
-384 Reduced 4.49%
8,177 $741,000
Q3 2022

Nov 09, 2022
BUY
$74.61 - $87.26 $154,964 - $181,239
2,077 Added 32.03%
8,561 $651,000
Q1 2022

May 02, 2022
SELL
$80.11 - $90.62 $1,842 - $2,084
-23 Reduced 0.35%
6,484 $569,000
Q4 2021

Feb 09, 2022
BUY
$79.7 - $88.13 $11,397 - $12,602
143 Added 2.25%
6,507 $569,000
Q1 2021

May 14, 2021
SELL
$83.5 - $98.47 $16,700 - $19,694
-200 Reduced 3.05%
6,364 $544,000
Q4 2020

Feb 12, 2021
SELL
$78.07 - $94.43 $97,587 - $118,037
-1,250 Reduced 16.0%
6,564 $620,000
Q3 2020

Nov 12, 2020
BUY
$82.14 - $91.0 $31,623 - $35,035
385 Added 5.18%
7,814 $680,000
Q2 2020

Aug 04, 2020
SELL
$80.93 - $91.1 $2,751 - $3,097
-34 Reduced 0.46%
7,429 $649,000
Q4 2019

Feb 05, 2020
SELL
$84.35 - $95.37 $2,277 - $2,574
-27 Reduced 0.36%
7,463 $707,000
Q3 2019

Nov 04, 2019
SELL
$85.54 - $94.26 $2,395 - $2,639
-28 Reduced 0.37%
7,490 $651,000
Q2 2019

Aug 06, 2019
SELL
$75.4 - $92.8 $12,214 - $15,033
-162 Reduced 2.11%
7,518 $686,000
Q1 2019

May 01, 2019
SELL
$75.32 - $86.15 $17,172 - $19,642
-228 Reduced 2.88%
7,680 $738,000
Q4 2018

Feb 06, 2019
BUY
$73.66 - $82.02 $81,909 - $91,206
1,112 Added 16.36%
7,908 $679,000
Q3 2018

Nov 07, 2018
SELL
$66.94 - $77.43 $40,833 - $47,232
-610 Reduced 8.24%
6,796 $586,000
Q2 2018

Aug 01, 2018
SELL
$64.91 - $73.36 $2.27 Million - $2.57 Million
-34,973 Reduced 82.52%
7,406 $559,000
Q1 2018

May 07, 2018
BUY
$70.39 - $84.15 $1.99 Million - $2.38 Million
28,260 Added 200.16%
42,379 $3.43 Million
Q4 2017

Feb 09, 2018
BUY
$72.33 - $77.64 $497,268 - $533,775
6,875 Added 94.91%
14,119 $1.19 Million
Q3 2017

Nov 06, 2017
BUY
$74.14 - $77.27 $537,070 - $559,743
7,244
7,244 $622,000

Others Institutions Holding NVS

# of Institutions
1,435
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Montag A & Associates Inc Portfolio

Follow Montag A & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email